Dae Hwa Pharm Co (XKRX:067080) 3-Year Revenue Growth Rate : 8.20% (As of Mar. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Dae Hwa Pharm Co 3-Year Revenue Growth Rate?

Dae Hwa Pharm Co's Revenue per Share for the three months ended in Mar. 2024 was ₩1,980.64.

During the past 12 months, Dae Hwa Pharm Co's average Revenue per Share Growth Rate was 6.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was 8.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was 5.20% per year. During the past 10 years, the average Revenue per Share Growth Rate was -0.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Dae Hwa Pharm Co was 33.30% per year. The lowest was -7.50% per year. And the median was 3.00% per year.

Competitive Comparison of Dae Hwa Pharm Co's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Dae Hwa Pharm Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dae Hwa Pharm Co's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dae Hwa Pharm Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Dae Hwa Pharm Co's 3-Year Revenue Growth Rate falls into.

Dae Hwa Pharm Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Dae Hwa Pharm Co (XKRX:067080) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Dae Hwa Pharm Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Dae Hwa Pharm Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Dae Hwa Pharm Co (XKRX:067080) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dae Hwa Pharm Co Ltd (XKRX:067080) » Definitions » 3-Year Revenue Growth Rate

Traded in Other Exchanges

N/A

Address

495 Hanu-ro, Hoengseong-eup, Hoengseong-gun, Seoul, Gangwon-do, KOR, 225-804

Website

http://www.dhpharm.co.kr

Dae Hwa Pharm Co Ltd is a specialized pharmaceutical company. It is mainly involved in manufacturing and distribution of pharmaceutical products. The company controls approximately 70% of the domestic transdermal drug delivery system market. The company offers analgesics and anti-inflammatory drugs, antihistamines, skeletal muscle relaxants, and cardiovascular drugs. Its products are exported to Asia, South America, Africa, and the Middle East.

Dae Hwa Pharm Co (XKRX:067080) Headlines

No Headlines